Skip to main content
Premium Trial:

Request an Annual Quote

Paracel Appoints Hiroshi Shishido as VP Managing Business Development

Premium

PASADENA, Calif.--The specialty bioinformatics hardware company Paracel here has named Hiroshi Shishido to the newly created position of vice-president of business development, where he will lead the formation of strategic bioinformatics partnerships overseas, among other responsibilities. Shishido will be based in Paracel's Foster City, Calif., branch office.

The former president and CEO of DZU Technology, Shishido has also worked as a business consultant specializing in building alliances in the computer industry. According to Kwang-I Yu, Paracel's president and CEO, Shishido "has time and again established or turned around high-technology businesses. His experience in building successful international operations for corporations such as Intel and MIPS Computer is especially valuable in a global bioinformatics market."

Shishido commented, "Paracel is in a unique position to meet the growing computational needs of genetic analysis researchers. The company's state-of-the-art technology, superior engineering capabilities, and supportive partnerships in the bioinformatics community give Paracel a rock-solid foundation for developing bioinformatics systems integration solutions that will set the standard for the industry."

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.